CVRx director receives new stock and option grants

CVRx, Inc. director Kirk G. Nielsen reported routine equity awards.

Rhea-AI Filing Summary

CVRx, Inc. director Kirk G. Nielsen reported routine equity awards. He received 8,720 shares of common stock as a grant at $0.00 per share and a stock option for 11,182 shares of common stock at an exercise price of $5.43 per share, expiring on June 1, 2036. The option vests on the earlier of June 1, 2027 or the company’s 2027 annual stockholders’ meeting. The filing also shows 1,910,134 common shares held indirectly through Vensana Capital I, L.P., where Nielsen shares voting and dispositive power but disclaims beneficial ownership beyond his pecuniary interest.

Insider Trade Summary

Grant/Award: 19,902 shares

Grant/Award 3 txns

Insider Nielsen Kirk G.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	11,182	$0.00	$0.00
Grant/Award	Common Stock	8,720	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 11,182 contracts (Direct); Common Stock — 8,720 shares (Direct); Common Stock — 1,910,134 shares (Indirect, See footnote)

Footnotes (2)

1. F1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.
2. F2. These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

Key Figures

Direct common shares granted: 8,720 shares Option shares granted: 11,182 shares Option exercise price: $5.43 per share +4 more

7 metrics

Direct common shares granted 8,720 shares Common Stock grant at $0.00 per share on June 1, 2026

Option shares granted 11,182 shares Stock Option (right to buy) granted on June 1, 2026

Option exercise price $5.43 per share Conversion or exercise price for 11,182-share option

Option expiration June 1, 2036 Expiration date of Stock Option (right to buy)

Indirectly held shares 1,910,134 shares Common Stock held by Vensana Capital I, L.P.

Direct common shares after grant 8,720 shares Total directly held non-derivative common stock following transaction

Option vesting trigger Earlier of June 1, 2027 or 2027 annual meeting Vesting condition for 11,182-share option grant

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, pecuniary interest, dispositive power, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)" for 11,182 shares"

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

pecuniary interest financial

"disclaims beneficial ownership except to the extent of his actual pecuniary interest"

dispositive power financial

"shares voting and dispositive power over the shares held by Vensana I"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

indirect financial

"ownership_type: "indirect" for shares held by Vensana Capital I, L.P."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CVRx (CVRX) director Kirk G. Nielsen report?

Kirk G. Nielsen reported equity compensation awards, not open-market trades. He received 8,720 shares of CVRx common stock as a grant and a stock option for 11,182 shares, both dated June 1, 2026, under the company’s equity compensation arrangements.

How many CVRx (CVRX) shares did Kirk G. Nielsen acquire directly in this Form 4?

The Form 4 shows a direct grant of 8,720 CVRx common shares to Kirk G. Nielsen at $0.00 per share. These are compensation-related shares, not purchased in the market, and increase his directly held non-derivative common stock position to 8,720 shares.

What are the terms of Kirk G. Nielsen’s new CVRx (CVRX) stock option grant?

Nielsen received a stock option covering 11,182 CVRx common shares at an exercise price of $5.43 per share. The option expires on June 1, 2036 and vests on the earlier of June 1, 2027 or the company’s 2027 annual meeting of stockholders.

How many CVRx (CVRX) shares are reported as indirectly held through Vensana Capital I, L.P.?

The filing reports 1,910,134 CVRx common shares indirectly held by Vensana Capital I, L.P. Nielsen is a managing director of its general partner and shares voting and dispositive power but disclaims beneficial ownership except for his actual pecuniary interest in those shares.

Does this CVRx (CVRX) Form 4 show any insider buying or selling in the open market?

The Form 4 does not show open-market buying or selling. It reflects compensation-related acquisitions: a grant of 8,720 common shares and a stock option for 11,182 shares, along with disclosure of large indirect holdings through Vensana Capital I, L.P.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 06:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nielsen Kirk G.

(Last) (First) (Middle)

9201 WEST BROADWAY AVE

SUITE 650

(Street)

MINNEAPOLIS MINNESOTA 55445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		8,720(1)	A	$0	8,720	D
Common Stock								1,910,134	I	See footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.43	06/01/2026		A		11,182		(1)	06/01/2036	Common Stock	11,182	$0	11,182	D

Explanation of Responses:

1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

2. These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

	/s/ Amy C. Seidel, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)